Abstract
A physiological flow model is presented to account for plasma level double peaks based on cyclical gastric emptying and intestinal motility in the fasted state. Central to the model is the assumption that gastric emptying and intestinal transit rates will vary directly with the strength of the contractile activity characteristic of the fasted state motility cycle. Simulated curves clearly indicate that variable gastric emptying rates can result in variable absorption rates from the gastrointestinal tract and double peaks in the plasma level curves of cimetidine. Vital to the occurrence of double peaks are (i) dosing time relative to phasic activity, (ii) variability in flow out of the stomach, and (iii) a small emptying rate constant Qs/Vs, for a period of time within the first hour after administration. Variability in intestinal flow rates alone does not cause a double peak in the plasma level curve. Results of the simulations, as well as experimental results, can be categorized according to the shapes of the plasma level curves into four types: type A, Cpmax(1) <Cpmax(2); type B, single peak; type C, Cpmax(1)>Cpmax(2); type D, Cpmax(1)=Cpmax(2). Assuming that the experimental results were obtained from fasted subjects, with the time of dose administration being a random variable, the frequency of the experimental curves having shape A, B, C, or D correlates extremely well with theoretical predictions. It is concluded that variable gastric emptying rates due to the motility cycle can account for plasma level double peaks. Furthermore, variable gastric emptying rates combined with the short plasma elimination half-life and poor gastric absorption of cimetidine can be the cause of the frequently observed plasma level double peaks.
Similar content being viewed by others
Abbreviations
- A s :
-
Amount of drug in the stomach
- A d :
-
Amount of drug in the duodenum
- A j :
-
Amount of drug in the jejunum
- A i :
-
Amount of drug in the ileum
- A p :
-
Amount of drug in the plasma
- A t :
-
Amount of drug in the peripheral compartment
- Q s :
-
Flow rate exiting the stomach
- Q d :
-
Flow rate exiting the duodenum
- Q j :
-
Flow rate exiting the jejunum
- Q i :
-
Flow rate exiting the ileum
- V s :
-
Volume of stomach contents
- V d :
-
Volume of duodenal contents
- V j :
-
Volume of jejunal contents
- V i :
-
Volume of ileal contents
- V p :
-
Volume of distribution
- V os :
-
Initial volume of stomach contents
- K as :
-
Absorption rate constant of cimetidine from the stomach
- K ad :
-
Absorption rate constant of cimetidine from the duodenum
- K aj :
-
Absorption rate constant of cimetidine from the jejunum
- K ai :
-
Absorption rate constant of cimetidine from the ileum
- K 12 :
-
Distribution rate constant of cimetidine from plasma to tissue
- K 21 :
-
Distribution rate constant of cimetidine from tissue to plasma
- K 10 :
-
Elimination rate constant of cimetidine from the plasma
- I :
-
Input of drug into the plasma from the gastrointestinal tract
- DER :
-
Emptying rate of the drug from the stomach into the duodenum
- C pmax(1):
-
First maximum drug concentration in the plasma
- C pmax(2):
-
Second maximum drug concentration in the plasma
- t max(1):
-
Time of first maximum drug concentration in the plasma
- t max(2):
-
Time of second maximum drug concentration in the plasma
References
R. C. Heading, J. Nimmo, L. F. Prescott, and P. Tothill. The dependence of paracetamol absorption on the rate of gastric emptying.Br. J. Pharmacol. 47:415–421 (1973).
R. R. Levine. Factors affecting gastrointestinal absorption of drugs.Dig. Dis. 15:171–188 (1970).
W. S. Nimmo, R. C. Heading, J. Wilson, P. Tothill, and L. F. Prescott. Inhibition of gastric emptying and drug absorption by narcotic analgesics.Br. J. Clin. Pharmacol. 2:509–513 (1975).
J. A. Clements, R. C. Heading, W. S. Nimmo, and L. F. Prescott. Kinetics of acetaminophen absorption and gastric emptying in man.Clin. Pharmacol. Ther. 24:420–431 (1978).
W. S. Nimmo. Drugs, disease, and altered gastric emptying.Clin. Pharmacokin. 1:189–203 (1976).
A. Grahnen, C. von Bahr, B. Lindstrom, and A. Rosen. Bioavailability and pharmacokinetics of cimetidine.Eur. J. Clin. Pharmacol. 16:335–340 (1979).
J. Webster, H. E. Barber, G. M. Hawksworth, T. A. Jeffers, J. Peterson, J. C. Petrie, P. W. Brunt, N. A. G. Mowat, and R. Griffiths. Cimetidine—a clinical and pharmacokinetic study.Br. J. Clin. Pharmacol. 11: 333–338 (1981).
G. Bodemar, B. Norlander, L. Fransson, and A. Walan. The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine: studies in patients with peptic ulcer.Br. J. Clin. Pharmacol. 7:23–31 (1979).
S. S. Walkenstein, J. W. Dubb, W. C. Randolph, W. J. Westlake, R. M. State, and A. P. Intoccia. Bioavailability of cimetidine in man.Gastroenterology 74:360–365 (1978).
J. G. Wagner. Unusual pharmacokinetics. In L. Z. Benet, G. Levy, and B. L. Ferraiolo (eds.),Pharmacokinetics—A Modern View, Plenum Press, New York, 1984, pp. 173–189.
U. Shukla. The pharmacokinetics of sobrerol in normal human volunteers. Ph.D. Dissertation, University of Michigan, 1985, pp. 115–117.
M. M. Hammarlund, L. K. Paalzow, and B. Odlind. Pharmacokinetics of furosemide in man after intravenous and oral administration: application of moment analysis.Eur. J. Clin. Pharmacol. 26:197–207 (1984).
C. Y. Lui, R. Oberle, D. Fleisher, and G. L. Amidon. A radiotelemetric method for evaluation of enteric coating performance: comparison of enteric coated and plain aspirin tablets.J. Pharm. Sci. 75:469–474 (1986).
P. Veng-Pedersen. Pharmacokinetics and bioavailability of cimetidine in humans.J. Pharm. Sci. 69:394–398 (1980).
P. Veng-Pedersen. Pharmacokinetic analysis of linear system approach I: Cimetidine bioavailability and second peak phenomenon.J. Pharm. Sci. 70:32–38 (1981).
R. W. Spence, L. R. Celestin, R. De La Guardia, C. A. MacMullen, and D. A. McCormick. Biliary secretion of cimetidine in man. InProceedings of the 2nd International Symposium on Histamine H2-Receplor Antagonists, Excerpta Medica, Amsterdam, The Netherlands, 1977, p. 81.
C. F. Code and J. A. Marlett. The interdigestive myoelectric complex of the stomach and small bowel of dogs.J. Physiol. 246:289–309 (1975).
M. L. Grivel and Y. Ruckebusch. The propagation of segmental contraction along the small intestine.J. Physiol. 227:611–625 (1972).
L. Bueno, J. Fioramonti, and Y. Ruckebusch. Rate of flow of digesta and electrical activity of the small intestine in dogs and sheep.J. Physiol. 249:69–85 (1975).
J. E. Kellow, T. J. Borody, S. F. Phillips, R. L. Tucker, and A. C. Haddad. Human interdigestive motility: variations in patterns from esophagus to colon.Gastroenterology 91:386–395 (1986).
C. F. Code and J. Schlegel. The gastrointestinal interdigestive housekeeper: motor correlates of the interdigestive myoelectric complex of the dog. In E. E. Daniel (ed.),Proceedings of the Fourth International Symposium of GI Motility, Mitchell Press, Vancouver, 1973, pp. 631–634.
P. Fleckenstein. Migrating electrical spike activity in the fasting human small intestine.Dig. Dis. 23:769–775 (1978).
S. K. Sarna, H. V. Ammon, L. G. Walter, and R. P. Ryan. Relationship between different phases of MMC and transit time: A reappraisal.Gastroenterology 88:1570 (1985).
S. K. Sarna. Cyclic motor activity; migrating motor complex: 1985.Gastroenterology 89:894–913 (1985).
C. P. Dooley, D. Mello, and J. E. Valenzuela. Effects of aspirin and prostaglandin E2 on interdigestive motility complex and duodenal reflux in man.Dig. Dis. Sci. 30:513–521 (1985).
P. Kerlin and S. Phillips. Variability of motility of the ileum and jejunum in healthy humans.Gastroenterology 82:694–700 (1982).
P. Fleckenstein and A. Oigaard. Electrical spike activity in the human small intestine: a multiple electrode study of fasting diurnal variationsDig. Dis. 23:776–780 (1978).
H. W. Davenport.Physiology of the Digestive Tract, 2nd ed., Year Book Medical Publishers Inc., Chicago, 1966, p. 44.
P. Kerlin, A. Zinsmeister, and S. Phillips. Relationship of motility to flow of contents in the human small intestine.Gastroenterology 82:701–706 (1982).
J. N. Hunt and I. MacDonald. The influence of volume on gastric emptying.J. Physiol. 126:459–474 (1954).
D. N. Bateman and T. A. Whittingham. Measurement of gastric emptying by real-time ultrasound.Gut 23:524–527 (1982).
P. K. Gupta, A. Rubinstein, and J. R. Robinson. Gastric emptying of liquids in fasted dog. (abstract)Pharm. Res. 3:74S (1986).
R. F. A. Logan, J. A. H. Forrest, G. P. McLoughlin, G. Lidgard, and R. C. Heading. Effect of cimetidine on serum gastrin and gastric emptying in man.Digestion 18:220–226 (1978).
L. R. Johnson ed.Physiology of the Digestive Tract, 2nd ed., Raven Press, New York, 1981, pp. 906–912.
D. N. Granger, J. A. Barrowman, and P. R. Kvietys.Clinical Gastrointestinal Physiology, W. B. Saunders, Philadelphia, 1985, pp. 105–108.
R. R. Berardi, I. A. Cohen, M. L. Hyneck, G. F. Lockwood, U. A. Shukla, E. Sakmar, J. J. Wells, and J. G. Wagner. Comparative bioavailability study of two tablet formulations of cimetidine.Biopharm. Drug Dispos. 5:169–176 (1984).
Author information
Authors and Affiliations
Additional information
This work was supported by the Smith Kline Beckman Corporation and the American Foundation for Pharmaceutical Education.
Rights and permissions
About this article
Cite this article
Oberle, R.L., Amidon, G.L. The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon. Journal of Pharmacokinetics and Biopharmaceutics 15, 529–544 (1987). https://doi.org/10.1007/BF01061761
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01061761